SG Americas Securities
ARRY

SG Americas Securities’s Array Biopharma Inc ARRY Stock Holding History

SG Americas Securities’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-381,771
Closed -$17.7M – 3392
2019
Q2 		$17.7M Buy
381,771
+369,087
+2,910% +$10.4M 0.12% 137
2019
Q1 		$309K Buy
+12,684
New +$264K ﹤0.01% 2240
2018
Q3 		– Sell
-10,973
Closed -$184K – 3624
2018
Q2 		$184K Sell
10,973
-5,092
-32% -$81K ﹤0.01% 2658
2018
Q1 		$262K Buy
+16,065
New +$257K ﹤0.01% 2258
2017
Q4 		– Sell
-71,582
Closed -$880K – 3855
2017
Q3 		$880K Buy
71,582
+53,731
+301% +$499K 0.01% 1359
2017
Q2 		$149K Sell
17,851
-22,136
-55% -$181K ﹤0.01% 2636
2017
Q1 		$357K Sell
39,987
-25,939
-39% -$276K ﹤0.01% 2071
2016
Q4 		$579K Buy
65,926
+55,865
+555% +$411K ﹤0.01% 1610
2016
Q3 		$68K Buy
+10,061
New +$38.9K ﹤0.01% 3148
2016
Q2 		– Sell
-20,080
Closed -$59K – 3173
2016
Q1 		$59K Buy
+20,080
New +$60.2K ﹤0.01% 2744
2015
Q4 		– Sell
-34,003
Closed -$155K – 3107
2015
Q3 		$155K Buy
34,003
+20,096
+145% +$119K ﹤0.01% 1613
2015
Q2 		$100K Sell
13,907
-2,872
-17% -$21.2K ﹤0.01% 2372
2015
Q1 		$124K Sell
16,779
-4,921
-23% -$35K ﹤0.01% 2151
2014
Q4 		$103K Buy
+21,700
New +$85.8K ﹤0.01% 2905
2013
Q4 		– Sell
-22,007
Closed -$137K – 3189
2013
Q3 		$137K Sell
22,007
-53,812
-71% -$320K ﹤0.01% 2453
2013
Q2 		$344K Buy
+75,819
New +$408K ﹤0.01% 1438

Other funds holding ARRY

ASN
Advisory Services Network Atlanta, Georgia $8.83B AUM 38.5% 1-Year Est. Return

SG Americas Securities's ARRY Position: Q3 2019 in Review

SG Americas Securities sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 381,771 shares — an estimated $17.7M sold.

SG Americas Securities first reported a position in ARRY in Q2 2013 and held it in 16 quarters. The position peaked at $17.7M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

  • SG Americas Securities reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
  • SG Americas Securities sold 381,771 Array Biopharma Inc shares in Q3 2019, an estimated $17.7M.
  • SG Americas Securities first reported a position in Array Biopharma Inc in Q2 2013 and held it in 16 quarters.
  • SG Americas Securities's Array Biopharma Inc position peaked at $17.7M in Q2 2019.
  • 1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on SG Americas Securities's 13F filing for Q3 2019, filed 4 Nov 2019.